NYVEPRIA
Google image searchProduct monograph
Active ingredient
pegfilgrastim, 6 MG/0.6 ML
DIN: 02506238
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE USE PREFILLED SYRINGE
Schedule: Prescription / Schedule D
Company: PFIZER CANADA ULC
Date: 18-JAN-2021
ATC:
- L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
- L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
- L03AA — Colony stimulating factors (ATC, ATC/DDD)
- L03AA13 — PEGFILGRASTIM (ATC/DDD)
Reference brand drug: Neulasta
